2533.T
Oenon Holdings, Inc. [2533.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2533.T Stock Summary
Top 10 Correlated Stocks
2533.T
In the News
2533.T Financial details
Company Rating
Buy
Market Cap
22.12B
Income
2.12B
Revenue
85.24B
Book val./share
346.74
Cash/share
15.82
Dividend
5
Dividend %
1.33%
Employees
803
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
10.37
Forward P/E
-
PEG
0.17
P/S
0.26
P/B
1.09
P/C
23.77
P/FCF
-
Quick Ratio
0.62
Current Ratio
0.97
Debt / Equity
0.4
LT Debt / Equity
0.09
-
-
EPS (TTM)
36.36
EPS next Y
-
EPS next Q
-
EPS this Y
-583.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.01%
Revenue Q/Q
-10.83%
EPS Q/Q
-63.08%
-
-
-
-
SMA20
-0.76%
SMA50
-12.65%
SMA100
8.79%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
11%
ROC
0.1%
Gross Margin
15%
Oper. Margin
3%
Profit Margin
2%
Payout
-
Shs Outstand
58.21M
Shs Float
37.18M
-
-
-
-
Target Price
-
52W Range
233.0-463.0
52W High
-18.79%
52W Low
+61.37%
RSI
42.99
Rel Volume
0.56
Avg Volume
245.19K
Volume
136.8K
Perf Week
-1.31%
Perf Month
-3.84%
Perf Quarter
-2.59%
Perf Half Y
9.3%
-
-
-
-
Beta
0.007
-
-
Volatility
4.13%, 12.17%
Prev Close
0.27%
Price
376
Change
-0.53%
2533.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.28K | 1.25K | 1.3K | 1.32K | 1.37K | |
| Net income per share | 7.76 | 18.27 | 19.25 | 5.03 | -24.32 | |
| Operating cash flow per share | 61.81 | 65 | 79.92 | 26.08 | -14.52 | |
| Free cash flow per share | 61.81 | 65 | 79.92 | 26.08 | -14.52 | |
| Cash per share | 20.9 | 17.74 | 12.42 | 14.6 | 15.17 | |
| Book value per share | 315.64 | 327.4 | 335.54 | 336.72 | 299.88 | |
| Tangible book value per share | 342.68 | 354.75 | 366.39 | 365.89 | 321.53 | |
| Share holders equity per share | 315.64 | 327.4 | 335.54 | 336.72 | 299.88 | |
| Interest debt per share | 67.05 | 45.25 | 38.7 | 67.49 | 161.13 | |
| Market cap | 20.97B | 23.98B | 24.43B | 21.4B | 15.23B | |
| Enterprise value | 23.69B | 25.46B | 25.76B | 24.36B | 23.79B | |
| P/E ratio | 44.71 | 21.73 | 21.3 | 71.56 | -10.57 | |
| Price to sales ratio | 0.27 | 0.32 | 0.31 | 0.27 | 0.19 | |
| POCF ratio | 5.61 | 6.11 | 5.13 | 13.8 | -17.7 | |
| PFCF ratio | 5.61 | 6.11 | 5.13 | 13.8 | -17.7 | |
| P/B Ratio | 1.1 | 1.21 | 1.22 | 1.07 | 0.86 | |
| PTB ratio | 1.1 | 1.21 | 1.22 | 1.07 | 0.86 | |
| EV to sales | 0.31 | 0.34 | 0.33 | 0.31 | 0.29 | |
| Enterprise value over EBITDA | 6.99 | 7.82 | 6.23 | 8.02 | 20.41 | |
| EV to operating cash flow | 6.34 | 6.48 | 5.41 | 15.71 | -27.67 | |
| EV to free cash flow | 6.34 | 6.48 | 5.41 | 15.71 | -27.67 | |
| Earnings yield | 0.02 | 0.05 | 0.05 | 0.01 | -0.09 | |
| Free cash flow yield | 0.18 | 0.16 | 0.19 | 0.07 | -0.06 | |
| Debt to equity | 0.21 | 0.13 | 0.11 | 0.2 | 0.53 | |
| Debt to assets | 0.07 | 0.05 | 0.04 | 0.08 | 0.17 | |
| Net debt to EBITDA | 0.8 | 0.45 | 0.32 | 0.97 | 7.35 | |
| Current ratio | 1.05 | 1.06 | 1.06 | 1.01 | 0.95 | |
| Interest coverage | 19.53 | 27.38 | 37.02 | 20.12 | -7.19 | |
| Income quality | 5.22 | 2.51 | 2.65 | 3.34 | 1.11 | |
| Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Payout ratio | 0.91 | 0.39 | 0.37 | 1.4 | -0.3 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 234.77 | 366.9 | 381.24 | 195.23 | 405.11 | |
| ROIC | 0.05 | 0.06 | 0.07 | 0.03 | -0.04 | |
| Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.01 | -0.03 | |
| Graham Net | -210.88 | -218.19 | -208.43 | -221.09 | -302.22 | |
| Working capital | 1.33B | 1.46B | 1.52B | 246M | -1.44B | |
| Tangible asset value | 20.71B | 21.43B | 21.83B | 21.75B | 19.05B | |
| Net current asset value | -3.95B | -5.04B | -4.16B | -4.64B | -8.87B | |
| Invested capital | 0.21 | 0.13 | 0.11 | 0.2 | 0.53 | |
| Average receivables | 20.35B | 18.32B | 17.07B | 16.69B | 16.74B | |
| Average payables | 5.13B | 4.84B | 4.78B | 4.7B | 4.87B | |
| Average inventory | 7.38B | 7.19B | 7.37B | 7.69B | 8.23B | |
| Days sales outstanding | 92.17 | 82.98 | 79.75 | 76.11 | 76.86 | |
| Days payables outstanding | 28.01 | 28.95 | 26.91 | 26 | 25.72 | |
| Days of inventory on hand | 41.68 | 42.97 | 43.02 | 43.52 | 43.86 | |
| Receivables turnover | 3.96 | 4.4 | 4.58 | 4.8 | 4.75 | |
| Payables turnover | 13.03 | 12.61 | 13.56 | 14.04 | 14.19 | |
| Inventory turnover | 8.76 | 8.49 | 8.49 | 8.39 | 8.32 | |
| ROE | 0.02 | 0.06 | 0.06 | 0.01 | -0.08 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 186.51 | 390.39 | 358.3 | 374.73 | 334.15 | |
| Net income per share | -6.45 | 1 | 13.7 | 15.82 | 5.84 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 6 | 15.17 | 12.31 | 10.67 | 15.82 | |
| Book value per share | 175.15 | 299.88 | 314.55 | 336.11 | 346.74 | |
| Tangible book value per share | 187.78 | 321.53 | 335.83 | 341.08 | 351.76 | |
| Share holders equity per share | 175.15 | 299.88 | 314.55 | 336.11 | 346.74 | |
| Interest debt per share | 107 | 160.24 | 191.3 | 154.6 | 139.68 | |
| Market cap | 28.83B | 15.23B | 16B | 20.26B | 24.68B | |
| Enterprise value | 39.44B | 23.79B | 26.39B | 28.61B | 31.87B | |
| P/E ratio | -10.61 | 64.52 | 5.02 | 5.5 | 18.15 | |
| Price to sales ratio | 1.47 | 0.66 | 0.77 | 0.93 | 1.27 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 1.56 | 0.86 | 0.87 | 1.04 | 1.22 | |
| PTB ratio | 1.56 | 0.86 | 0.87 | 1.04 | 1.22 | |
| EV to sales | 2.01 | 1.03 | 1.27 | 1.31 | 1.64 | |
| Enterprise value over EBITDA | -56.02 | 132.19 | 29.12 | 23.07 | 59.46 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | -0.02 | 0 | 0.05 | 0.05 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.61 | 0.53 | 0.61 | 0.46 | 0.4 | |
| Debt to assets | 0.21 | 0.17 | 0.21 | 0.17 | 0.15 | |
| Net debt to EBITDA | -15.07 | 47.6 | 11.47 | 6.74 | 13.41 | |
| Current ratio | 0.96 | 0.95 | 0.96 | 0.96 | 0.97 | |
| Interest coverage | -38 | 6.23 | 36.5 | 50.13 | 22.77 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 159.48 | 81.97 | 311.38 | 345.91 | 213.47 | |
| ROIC | -0.02 | 0 | 0.03 | 0.03 | 0.01 | |
| Return on tangible assets | -0.01 | 0 | 0.01 | 0.02 | 0.01 | |
| Graham Net | -161.78 | -302.22 | -293.86 | -279.17 | -281.46 | |
| Working capital | -934M | -1.44B | -1.03B | -911M | -751M | |
| Tangible asset value | 19.76B | 19.05B | 19.54B | 19.85B | 20.48B | |
| Net current asset value | -8.33B | -8.87B | -8.29B | -8.1B | -7.75B | |
| Invested capital | 0.61 | 0.53 | 0.61 | 0.46 | 0.4 | |
| Average receivables | 13.49B | 15.35B | 15.96B | 14.24B | 14.53B | |
| Average payables | 4.62B | 4.95B | 4.91B | 4.83B | 4.71B | |
| Average inventory | 8.52B | 8.65B | 9.02B | 9.11B | 8.8B | |
| Days sales outstanding | 62.44 | 66.47 | 64.11 | 56.26 | 71.39 | |
| Days payables outstanding | 24.47 | 22.52 | 24.57 | 24.3 | 24.94 | |
| Days of inventory on hand | 43.92 | 38.39 | 48.5 | 43.78 | 48.39 | |
| Receivables turnover | 1.44 | 1.35 | 1.4 | 1.6 | 1.26 | |
| Payables turnover | 3.68 | 4 | 3.66 | 3.7 | 3.61 | |
| Inventory turnover | 2.05 | 2.34 | 1.86 | 2.06 | 1.86 | |
| ROE | -0.04 | 0 | 0.04 | 0.05 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
2533.T Frequently Asked Questions
What is Oenon Holdings, Inc. stock symbol ?
Oenon Holdings, Inc. is a JP stock and trading under the symbol 2533.T
What is Oenon Holdings, Inc. stock quote today ?
Oenon Holdings, Inc. stock price is $376 today.
Is Oenon Holdings, Inc. stock public?
Yes, Oenon Holdings, Inc. is a publicly traded company.
Company Profile
- Volume Average 245.19K
- Market Capitalization 22.12B
- Employee 803
- CEO Mr. Yuji Nishinaga
- Headquarters Tokyo,JP
- IPO Date 2001-01-01
-
Website
https://www.oenon.jp 
Oenon Holdings, Inc. develops alcoholic beverages, food products, enzymes and pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, chu-hi, sake, sake compounds, umeshu plum wine, processed liquor, wine, brewing and industrial alcohol, seasonings, and other products. It also manufacture and sell enzymes for food and industrial use comprising lactase, a lactose hydrolytic enzyme; cellulase, a dietary fiber processing enzyme; glucose isomelase, a fructose corn syrup manufacturing enzyme; protease, a proteolytic enzyme; dispase, a cell dispersion enzyme; and isoamylase, a starch processing enzyme. In addition, the company offers active pharmaceutical ingredients, such as Pravastatin for hyperlipidemia treatment; Voglibose for diabetes mellitus treatment; starch for food processing; and diagnostic medicines and health foods. Further, it sells and leases real estate properties. Additionally, the company engages in transportation and cargo handling, and other activities. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.
